| 1 |
26636651 | Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model. | 2015 Dec 15 |
2 |
| 2 |
23624369 | Rapidly growing pancreatic ductal adenocarcinoma in a patient with metastatic melanoma and harbouring CDKN2A germline mutation: a new vemurafenib-induced malignancy? | 2013 Jun |
1 |
| 3 |
22256804 | RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors. | 2012 Jan 19 |
1 |